SASKATOON, CANADA and GRAND JUNCTION, COLO. — Bioriginal Food & Science Corp. acquired all operating assets of Softgel Co. on Nov. 28. The acquisition includes a state-of-the-art facility that specializes in the encapsulation of human and pet nutrition products.
Softgel focuses on manufacturing soft gel, squeeze tube and tincture nutritional products for humans and pets. The company has more than a decade of encapsulation experience and the capability to produce more than one million soft gels per shift.
According to Bioriginal, the acquisition expands its presence in the United States and represents a “natural shift” in its growth. From seed or fish to bulk ingredients, milling, encapsulation, fill and finished product, Bioriginal will control the entire manufacturing process.
“Thanks to the support of our clients and partners, we are fortunate to be in a position where we can expand with industry leaders, like Softgel,” said Shannon Sears, president and chief executive officer of Bioriginal. “The addition of Softgel expands Bioriginal’s global supply abilities, removing the need to outsource soft gel production, improving production efficiencies and enhancing supply chain management. This level of vertical integration ensures what is on the label is in the bottle. Consumers deserve that level of confidence.”
Through the acquisition, Softgel will take immediate steps to double its capacity at its manufacturing facility to help meet Bioriginal’s demands.
Softgel represents the fourth business for Bioriginal to acquire this year, building on its acquisition of a pet treat manufacturing facility in the Netherlands, a plant-based oil processing plant in Germany, and a trading corporation in Yokohama, Japan.
With this latest acquisition under its belt, Bioriginal now operates seven manufacturing facilities, including offices in Canada, the United States, the Netherlands, Germany and Japan, supported by 18 warehouses worldwide.
Read more news from pet food and treat industry suppliers.